Cytosorbents Corp — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Dr. Phillip P. Chan (CEO) and Peter J. Mariani (CFO) certified the Form 10-Q for the quarter ended June 30, 2026, filed August 6, 2026. Both officers certify the report contains no untrue material statements, financial statements fairly present the company's condition and operations, and disclosure controls and internal controls over financial reporting are effective. No material weaknesses, deficiencies, or fraud disclosures are mentioned.
Why this rating
Routine Sarbanes-Oxley certifications; standard periodic disclosure with no substantive business changes, transactions, or control issues disclosed.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.